Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2014
09/02/2014US8822450 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
09/02/2014US8822448 Pyrazoloquinoline compound
09/02/2014US8822447 Indazole compounds useful as ketohexokinase inhibitors
09/02/2014US8822446 Pyrrolopyridine inhibitors of kinases
08/2014
08/28/2014WO2014130597A1 Electronic device including a diazachrysene derivative
08/28/2014WO2014128588A1 Solid forms of a selective cdk4/6 inhibitor
08/28/2014WO2014128585A1 Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014128465A1 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
08/28/2014WO2014128109A1 Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
08/28/2014US20140243531 Superstructures of diketopyrrolopyrrole donors and perylenediimide acceptors formed by hydrogen-bonding and pi...pi stacking
08/28/2014US20140243520 Pyrrolopyridines as kinase inhibitors
08/28/2014US20140243396 Method of treating mucoepidermoid carcinoma
08/28/2014US20140243367 Antiviral drugs for treatment of arenavirus infection
08/28/2014US20140243366 Compounds that modulate intracellular calcium
08/28/2014US20140243365 Compounds modulating c-fms and/or c-kit activity and uses therefor
08/28/2014US20140243361 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
08/28/2014US20140243346 Ip receptor agonist heterocyclic compounds
08/28/2014US20140243334 Substituted hydoxamic acids and uses thereof
08/28/2014US20140243328 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
08/28/2014US20140243321 Bioorthogonal monomers capable of dimerizing and targeting bromodomains, and methods of using same
08/28/2014US20140243302 Bridged bicyclic compounds for the treatment of bacterial infections
08/28/2014US20140243290 Aminopyrimidines as SYK Inhibitors
08/28/2014US20140243273 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
08/28/2014US20140242121 Novel imidazole quinoline-based immune system modulators
08/28/2014DE112012005176T5 Verfahren zum Synthetisieren von 1-(2-FluorbenzyI)-1H-pyrazolo[3,4-b]pyridin-3-formamidin-hydrochlorid A method of synthesizing 1- (2-FluorbenzyI) -1H-pyrazolo [3,4-b] pyridin-3-formamidine hydrochloride
08/28/2014DE102013003354A1 Verfahren zur Synthese von Graphen dadurch gekennzeichnet, dass das Graphen durch Verknüpfung von Aromaten mithilfe von Lithium und einem Halogen entsteht. Process for the synthesis of graphs characterized in that the graph by linking of aromatics using lithium and a halogen obtained. Verfahren zur Synthese von graphenähnlichen Substanzen dadurch gekennzeichnet, dass diese durch Verknüpfung von Aromaten mithilfe von Lithium und einem Halogen entstehen. A process for the synthesis of graphene-like substances characterized in that these by using linking of aromatics by lithium and a halogen arise.
08/27/2014EP2770036A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
08/27/2014EP2769980A1 Pyrazoloquinoline derivative
08/27/2014EP2768822A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/26/2014US8816085 Methylpyrrolopyridinecarboxamides
08/26/2014US8815894 Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
08/26/2014US8815891 Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
08/26/2014US8815873 Heterocyclic amides as rock inhibitors
08/26/2014US8815869 Lactam acetamides as calcium channel blockers
08/26/2014US8815861 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
08/26/2014US8815854 Substituted imidazopyridinyl compounds
08/26/2014US8815849 Hetero-bicyclic derivatives as HCV inhibitors
08/26/2014US8815845 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
08/26/2014US8815778 PH modulation method to detect ligand-receptor binding
08/21/2014WO2014125413A1 Ip receptor agonist heterocyclic compounds
08/21/2014WO2014100620A3 Compounds and methods for kinase modulation, and indications therefor
08/21/2014WO2014091298A3 Nitrogen containing morphinan derivatives and the use thereof
08/21/2014WO2014086453A8 Azaheterobicyclic compounds
08/21/2014US20140235864 Biphenyl derivatives
08/21/2014US20140235667 Imidazopyridyl compounds as aldosterone synthase inhibitors
08/21/2014US20140235666 Imidazopyridine derivatives which inhibit the secretion of gastric acid
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
08/21/2014US20140235647 Substituted bicyclic heteroaryl compounds
08/21/2014US20140235646 Methods and Compositions for the Treatment of Body Weight Related Disorders
08/21/2014US20140235645 Pyridine Compounds and Uses Thereof
08/21/2014US20140235644 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
08/21/2014US20140235628 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235616 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
08/21/2014US20140235612 Azabenzimidazole Compounds
08/21/2014US20140235609 Carbamate/urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/21/2014US20140234254 Heteroaromatic compounds as pi3 kinase modulators and methods of use
08/21/2014CA2807859A1 Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
08/20/2014EP2767537A1 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/20/2014EP2766363A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them
08/20/2014EP2766362A1 Solid forms of nematocidal sulfonamides
08/20/2014EP2766361A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
08/20/2014EP2766359A2 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/20/2014EP2766358A1 Novel oxazine derivatives and their use in the treatment of disease
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766344A1 Ep1 receptor ligands
08/19/2014US8809541 Heterocyclic compound, and composition for treating inflammatory diseases using same
08/19/2014US8809532 Aza-ring fused indole and indoline derivatives
08/19/2014US8809381 Highly selective sigma receptor ligands
08/19/2014US8809369 Tetrahydroquinoline derivatives
08/19/2014US8809364 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
08/19/2014US8809352 Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer
08/19/2014US8809332 Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
08/19/2014US8809313 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
08/19/2014CA2591970C Polyethylene glycolated superoxide dismutase mimetics
08/19/2014CA2545435C Hydroxy piperidine derivatives to treat gaucher disease
08/14/2014WO2014124418A1 Modulators of methyl modifying enzymes, compositions and uses thereof
08/14/2014WO2014124302A1 Fluorinated integrin antagonists
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
08/14/2014WO2014121883A1 Substituted acetylene derivatives and their use as positive allosteric modulators of mglur4
08/14/2014WO2009070485A8 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES
08/14/2014US20140228569 Novel compound having affinity for amyloid
08/14/2014US20140228396 Triazolopyridyl compounds as aldosterone synthase inhibitors
08/14/2014US20140228395 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
08/14/2014US20140228380 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
08/14/2014US20140228379 Pyrido-Pyrimidine Derivatives
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228369 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228366 Heteroaryl-substituted pyrazolopyridines and use thereof as soluble guanylate cyclase stimulators
08/14/2014US20140228362 Method of Treatment or Prophylaxis
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228355 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
08/14/2014US20140228353 Compounds and methods of treating diabetes
08/14/2014US20140228350 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 646